StonvexLoading…
StonvexCore line items from TGB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | C$672.90M | C$608.09M | C$524.97M | C$391.61M |
Operating Income | C$19.93M | C$103.70M | C$125.12M | C$55.86M |
Net Income | C$-30.08M | C$-13.44M | C$82.73M | C$-25.97M |
EPS (Diluted) | C$-0.09 | C$-0.05 | C$0.28 | C$-0.09 |
Total Assets | C$2.47B | C$2.20B | C$1.58B | C$1.28B |
Total Liabilities | C$1.69B | C$1.69B | C$1.15B | C$922.27M |
Cash & Equivalents | C$187.96M | C$172.73M | C$96.48M | C$120.86M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | Not available | 304.68M | 290.00M | 286.49M |